Docusate Sodium and Sennosides

Capsule, Gelatin Coated · Oral

Over the counter

Active ingredient

Active Ingredient Active Ingredient

Purpose

Purpose Purpose

Uses

Indications and Usage Indications & Usage

Warnings

Warnings Warnings Keep out or Reach of Children Keep out of Reach of Children

Keep out of reach of children

Keep out or Reach of Children Keep out of Reach of Children

Directions

Dosage and Administration Dosage & Administration

Other information

Storage and Handling Section Storage and Handling

Inactive ingredients

Inactive Ingredients Inactive Ingredients

Questions?

Questions or Comments Questions & Comments

Label text from the FDA structured product label by Morepen Bio Inc (revised Aug 14, 2026). Long sections are shortened; the complete label is on DailyMed.

Active ingredients

Docusate Sodium and Sennosides NDC products (5)

NDCStrength & formLabelerType
87717-502Docusate Sodium 50 mg/1; Sennosides 8.6 mg/1
Tablet
Morepen Bio IncOTC MONOGRAPH DRUG
62993-0002Docusate Sodium 50 mg/1; Sennosides 8.6 mg/1
Tablet
Morepen Laboratories LimitedOTC MONOGRAPH DRUG
35916-0453Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1
Capsule, Gelatin Coated
SOFTGEL HEALTHCARE PRIVATE LIMITEDOTC MONOGRAPH DRUG
35916-0454Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1
Capsule, Gelatin Coated
SOFTGEL HEALTHCARE PRIVATE LIMITEDOTC MONOGRAPH DRUG
35916-0477Docusate Sodium 50 mg/1; Sennosides 8.6 mg/1
Capsule, Liquid Filled
SOFTGEL HEALTHCARE PRIVATE LIMITEDOTC MONOGRAPH DRUG

Frequently asked questions

What is Docusate Sodium and Sennosides used for?

Indications and Usage Indications & Usage

Who makes Docusate Sodium and Sennosides?

Docusate Sodium and Sennosides is listed by 3 labelers in the FDA NDC directory, including Morepen Bio Inc, Morepen Laboratories Limited, SOFTGEL HEALTHCARE PRIVATE LIMITED.